Abstract: A memory system includes a memory, a control circuit, and an interface circuit. The interface circuit includes a first terminal capable of receiving a first clock supplied from an outside, and a second terminal capable of receiving a first signal. When in a first state, the control circuit transitions to a second state in response to input of a first signal, and to a third state in response to input of the first clock. When in the second state, the control circuit executes initialization processing of a first mode for an operation based on an internally generated second clock or is in an operable state in the first mode, and ends the operable state in the first mode in response to input of the first clock and transitions to the third state. When in the third state, the control circuit transitions to a fourth state in response to input of the first signal.

Abstract: A lacrimal duct tube includes: a pair of tubular members that each have at one end an opening communicating with a lumen; and a connection member that connects the other ends of the tubular members. A base end part including the other end of at least one of the tubular members is tapered down toward the connection member and the base end part has an inlet/outlet port communicating with the lumen of the tubular member. A portion of the base end part constituting peripheral edge of the inlet/outlet port and the connection member are connected together.

Abstract: A medical tube in which an intermediate layer composed of a composition containing (a), (b), and (c1) listed below and a lubricant layer composed of a composition containing (a), (b), and (c2) listed below are sequentially laminated on a surface of an insertion member to be inserted into a living body: (a) 1 to 35 weight % of at least one of aromatic diisocyanate, aliphatic diisocyanate, and alicyclic diisocyanate; (b) 1 to 35 weight % of trifunctional or higher functionality polyol; (c1) 30 to 98 weight % of polyalkylene glycol and/or monomethoxypolyalkylene glycol; and (c2) 30 to 98 weight % of polyalkylene glycol (including polyalkylene glycol larger in weight-average molecular weight than polyalkylene glycol in (c1)) and/or monomethoxypolyalkylene glycol (including monomethoxypolyalkylene glycol larger in weight-average molecular weight than monomethoxypolyalkylene glycol in (c1)), (where each of the glycols in (c1) and (c2) is diol).

Abstract: A memory system includes a non-volatile memory device and a memory controller. The memory controller includes a first counting circuit configured to count a number of times reading is performed on a first unit of data, a second counting circuit configured to count a number of times reading is performed on a second unit of data, which has a size smaller than that of the first unit of data and is a part of the first unit of data, when the number of times reading has been performed on the first unit of data exceeds a first threshold value, and a cache control circuit configured to cache the second unit of data in response to a read request for the second unit of data, when the number of times reading has been performed on the second unit of data exceeds a second threshold value.

Abstract: A lacrimal duct tube includes: a pair of tubular members that each have at one end an opening communicating with a lumen and have in a wall a hole for guiding a lacrimal duct tube operative instrument to the lumen; and a connection member that connects the other ends of the tubular members. Surfaces of the tubular members include a hydrophilic-coated portion and a non-coated portion without the hydrophilic coating. It is preferred that the lumen in the vicinity of the opening includes an engagement portion for engagement with a tip of the lacrimal duct tube operative instrument, and the non-coated portion is formed without overlapping with the surface of the tubular member at the position of the engagement portion. The lacrimal duct tube can be used favorably for various lacrimal duct obstruction treatments. In the case of using a sheath such as in sheath guided endoscopic probing, the lacrimal duct tube can be easily inserted into the sheath and be firmly fixed to the sheath.

Abstract: A lacrimal duct tube including: a pair of tubular members each of which has an terminal end opening at one end; and a central member that connects other ends of the tubular members, at least one of the tubular members includes: a cylindrical part extended from the terminal end opening to the central member side and has an opening for bar-like operative instrument at an end portion at the central member side; and an arc-shaped part that is extended from the end portion of the cylindrical part at the central member side further to the central member side and has an almost arc-shaped wall portion on a cross section orthogonal to a longitudinal side of the tubular member, and the almost arc-shaped wall portion is formed at the arc-shaped part continuously over a length of ? or more and 9/10 or less of an entire length of the tubular member.

Abstract: The present invention provides a lacrimal duct tube that can be preferably used for the treatment of lacrimal duct obstruction, in particular, sheath guided endoscopic probing having been frequently performed in recent years, the lacrimal duct tube being excellent in passage through a lesion in the lacrimal duct, operability in the lacrimal duct, and manipulation of the endoscope inserted into the lumen of the tube, and providing a sufficient viewing field of the endoscope. The present invention relates to a lacrimal duct tube, including: a pair of tubular members that each has an opening at one end and a hole in a side wall communicating with a lumen; and a connection member that connects other ends of the tubular members, wherein the tubular members each include a plurality of resin portions different in Shore hardness, at least one of the resin portions is positioned between the opening and the hole and forms a lumen wall of the tubular member, and the lumen wall has a Shore hardness of 57D or more.

Abstract: A lacrimal duct tube includes: a pair of tubular members that each have at one end an opening communicating with a lumen and have in a wall a hole for guiding a lacrimal duct tube operative instrument to the lumen; and a connection member that connects the other ends of the tubular members. Surfaces of the tubular members include a hydrophilic-coated portion and a non-coated portion without the hydrophilic coating. It is preferred that the lumen in the vicinity of the opening includes an engagement portion for engagement with a tip of the lacrimal duct tube operative instrument, and the non-coated portion is formed without overlapping with the surface of the tubular member at the position of the engagement portion. The lacrimal duct tube can be used favorably for various lacrimal duct obstruction treatments. In the case of using a sheath such as in sheath guided endoscopic probing, the lacrimal duct tube can be easily inserted into the sheath and be firmly fixed to the sheath.

Abstract: A lacrimal duct tube includes: a pair of tubular members that each have at one end an opening communicating with a lumen; and a connection member that connects the other ends of the tubular members. A base end part including the other end of at least one of the tubular members is tapered down toward the connection member and the base end part has an inlet/outlet port communicating with the lumen of the tubular member. A portion of the base end part constituting peripheral edge of the inlet/outlet port and the connection member are connected together.

Abstract: A lacrimal duct tube including: a pair of tubular members each of which has an terminal end opening at one end; and a central member that connects other ends of the tubular members, at least one of the tubular members includes: a cylindrical part extended from the terminal end opening to the central member side and has an opening for bar-like operative instrument at an end portion at the central member side; and an arc-shaped part that is extended from the end portion of the cylindrical part at the central member side further to the central member side and has an almost arc-shaped wall portion on a cross section orthogonal to a longitudinal side of the tubular member, and the almost arc-shaped wall portion is formed at the arc-shaped part continuously over a length of ? or more and 9/10 or less of an entire length of the tubular member.

Abstract: The present invention provides a lacrimal duct tube that can be preferably used for the treatment of lacrimal duct obstruction, in particular, sheath guided endoscopic probing having been frequently performed in recent years, the lacrimal duct tube being excellent in passage through a lesion in the lacrimal duct, operability in the lacrimal duct, and manipulation of the endoscope inserted into the lumen of the tube, and providing a sufficient viewing field of the endoscope. The present invention relates to a lacrimal duct tube, including: a pair of tubular members that each has an opening at one end and a hole in a side wall communicating with a lumen; and a connection member that connects other ends of the tubular members, wherein the tubular members each include a plurality of resin portions different in Shore hardness, at least one of the resin portions is positioned between the opening and the hole and forms a lumen wall of the tubular member, and the lumen wall has a Shore hardness of 57D or more.

Abstract: A medical tube in which an intermediate layer composed of a composition containing (a), (b), and (c1) listed below and a lubricant layer composed of a composition containing (a), (b), and (c2) listed below are sequentially laminated on a surface of an insertion member to be inserted into a living body: (a) 1 to 35 weight % of at least one of aromatic diisocyanate, aliphatic diisocyanate, and alicyclic diisocyanate; (b) 1 to 35 weight % of trifunctional or higher functionality polyol; (c1) 30 to 98 weight % of polyalkylene glycol and/or monomethoxypolyalkylene glycol; and (c2) 30 to 98 weight % of polyalkylene glycol (including polyalkylene glycol larger in weight-average molecular weight than polyalkylene glycol in (c1)) and/or monomethoxypolyalkylene glycol (including monomethoxypolyalkylene glycol larger in weight-average molecular weight than monomethoxypolyalkylene glycol in (c1)), (where each of the glycols in (c1) and (c2) is diol).

Abstract: A lacrimal duct tube (31) includes an integrated tube that is placed in a lacrimal duct and capable of insertion of an insertion aid (36) in a detachable manner. The tube (31) has a terminal end opening (33) at a terminal end. In the vicinity of the terminal end opening (33), a stopper part (32a, 32b, 32c, and 32d) for stopping the insertion aid (36) is inserted in the tube (31). The stopper part (32a, 32b, 32c, and 32d) is opened at both ends in an axial direction of the tube and has a cylindrical structure including an inner wall surface (37a, 37b, 37c, and 37d) to guide and stop the insertion aid (36).

Abstract: Receiver (2) sequentially switches a preset frequency change amount in stages from a large value to a small value. According to the reception side frequency change amount, the reception side frequency candidate for detecting a synchronization signal is calculated. Synchronization signal detection unit (5) detects a synchronization signal transmitted from a transmission device by using the calculated reception side frequency candidate. Moreover, transmitter (1) calculates a transmission side frequency candidate as a frequency candidate for transmitting the synchronization signal according to the largest possible frequency change amount calculated according to the bandwidth of the synchronization signal.

Abstract: A MIMO wireless communication system capable of relaxing a reduction in a transmission rate on a cell end far from a base station and ensuring a high transmission rate for a mobile station, irrespectively of a distance from the base station is provided. In a state 1, the mobile station 21 checks a propagation line quality and instructs only the first base station 11 to transmit data to the mobile station 21. In a state 2, the mobile station 21 issues a request to divide the data to the first base station 11 and the second base station 12 and to transmit the divided data to the mobile station 21, and holds MIMO communication with the two base stations. In a state 3, the mobile station 21 requests only the second base station 12 to transmit the data and communicates with the second base station 12.

Abstract: A corrected channel estimating apparatus is disclosed, which is capable of removing side-lobe components mutually leaking into transmission paths from channel estimates to increase the accuracy. A channel estimation unit calculates channel estimates for a plurality of transmission paths due to a signal that arrives through multipath. A channel estimate correction unit removes side-lobe components mutually leaking into the transmission paths from the channel estimates calculated by the channel estimation unit to correct the channel estimates. In this way, the corrected channel estimating apparatus estimates transmission paths of a multipath.

Abstract: A mobile communication system capable of improving the reception characteristic using a small circuit size and low power consumption is provided. The channel vector estimating section 181 estimates channel vectors in a method such as a method in which the section 181 multiplies, according to the multipath timings sent from the multipath timing detecting section, the input signal from the base-station receiving section by a complex conjugate of a known pilot signal to average the input signal (to average the input signal by de-spreading the pilot signal in the case of CDMA). The noise estimating section 182 estimates noise power using received signals and generates a Channel matrix by arranging the estimated channel vectors according to the multipath timings. The weight calculating section 184 calculates a weight matrix using the noise estimation value and the Channel matrix and sets the obtained filter weight vectors to the equalizing filter 185.

Abstract: Receiver (2) sequentially switches a preset frequency change amount in stages from a large value to a small value. According to the reception side frequency change amount, the reception side frequency candidate for detecting a synchronization signal is calculated. Synchronization signal detection unit (5) detects a synchronization signal transmitted from a transmission device by using the calculated reception side frequency candidate. Moreover, transmitter (1) calculates a transmission side frequency candidate as a frequency candidate for transmitting the synchronization signal according to the largest possible frequency change amount calculated according to the bandwidth of the synchronization signal.

Abstract: An wireless terminal includes a demodulating unit which comprises an FV (fading vector) estimating unit for receiving a CPICH spread/demodulated signal to output an FV signal with a reduced noise ratio; a phase synchronization unit for multiplying a PDSCH spread/demodulated signal with a complex conjugate of the FV signal to correct the phase offset of the PDSCH I and Q signals to send the resulting PDSCH I and Q signals to a multi-level QAM amplitude synchronization detection unit and to an amplitude demodulating unit; a first-quadrant transformation unit for collecting the second to fourth quadrant signals of the phase-synchronized PDSCH I and Q signals; and a threshold value detecting unit for calculating a multi-level QAM threshold value from the first quadrant signals and the FV signals to send the threshold signal to an amplitude demodulating unit. The amplitude demodulating unit effects amplitude demodulation to output multi-level QAM demodulated signals.